Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.
Professor of Medicine (Neurology), University of Ottawa; Ottawa, Ontario, Canada; Director, Multiple Sclerosis Research Unit, The Ottawa Hospital General Campus, Ottawa, Ontario, Canada
Disclosure: Mark Freedman, MD, has disclosed the following relevant financial relationships:
Received grants for clinical research from: Bayer HealthCare Pharmaceuticals; Genzyme Corporation
Served as an advisor or consultant for: Bayer HealthCare Pharmaceuticals; Biogen Idec Inc.; EMD Serono, Inc.; Novartis Pharmaceuticals Corporation; sanofi-aventis; Teva Neuroscience, Inc.
concerned wrote:None of those places seem to indicate whether or not he has stock or stake in the device. that was all i've been looking for here.
I have read over the past six months plenty of things about ccsvi, but nothing about Real Scientific Evidence. That kind of evidence is arrived at by using the "scientific method", otherwise it's just people waving around instruments in what Richard Feynman called a "Cargo Cult of Science" (we're waving these tools around and wearing a labcoat, now our god science will bless us!)
Why doesn't a radiologist here send data from 100 ms patients and 100 controls to zamboni and see if he could tell which patient had ms and which didn't without seeing the patients themselves. That would be a step on the right way toward proving or disproving this, as all the published reports incate, highly theoretical position. Jamming a cathater into a person with MS and then saying "You have MS" is not science.
Users browsing this forum: No registered users